272 related articles for article (PubMed ID: 22429150)
1. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
2. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.
Raicevic G; Najar M; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Cell Immunol; 2011; 270(2):207-16. PubMed ID: 21700275
[TBL] [Abstract][Full Text] [Related]
3. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
5. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
[TBL] [Abstract][Full Text] [Related]
6. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
[TBL] [Abstract][Full Text] [Related]
7. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
11. A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue.
Shafiee A; Seyedjafari E; Soleimani M; Ahmadbeigi N; Dinarvand P; Ghaemi N
Biotechnol Lett; 2011 Jun; 33(6):1257-64. PubMed ID: 21287233
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
[TBL] [Abstract][Full Text] [Related]
14. Gene expression and protein secretion during human mesenchymal cell differentiation into adipogenic cells.
Amable PR; Teixeira MV; Carias RB; Granjeiro JM; Borojevic R
BMC Cell Biol; 2014 Dec; 15():46. PubMed ID: 25526965
[TBL] [Abstract][Full Text] [Related]
15. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
18. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
19. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]